Gefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coatingGefitinib/gefitinib microspheres loaded polyurethane constructs as drug-eluting stent coating

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
In: 10.1016/j.ejps.2017.02.002

Ereignis
Veröffentlichung
(wo)
Aachen
(wer)
Universitätsbibliothek der RWTH Aachen
(wann)
2017
Urheber
Chen, Weiluan
Clauser, Johanna C.
Thiebes, Anja Lena
McGrath, Donnacha J.
Kelly, Nicola
van Steenbergen, Mies J.
Jockenhövel, Stefan
Steinseifer, Ulrich
McHugh, Peter E.
Hennink, Wim E.
Kok, Robbert J.

DOI
10.18154/RWTH-CONV-224021
URN
urn:nbn:de:101:1-2020052506373410782508
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:58 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Chen, Weiluan
  • Clauser, Johanna C.
  • Thiebes, Anja Lena
  • McGrath, Donnacha J.
  • Kelly, Nicola
  • van Steenbergen, Mies J.
  • Jockenhövel, Stefan
  • Steinseifer, Ulrich
  • McHugh, Peter E.
  • Hennink, Wim E.
  • Kok, Robbert J.
  • Universitätsbibliothek der RWTH Aachen

Entstanden

  • 2017

Ähnliche Objekte (12)

Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer

Fabrication and characterization of gefitinib-releasing polyurethane foam as a coating for drug-eluting stent in the treatment of bronchotracheal cancer

A New Synthesis of Gefitinib

A New Synthesis of Gefitinib

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer

Drittlinientherapie mit Gefitinib beim nicht-kleinzelligen Bronchialkarzinom

Drittlinientherapie mit Gefitinib beim nicht-kleinzelligen Bronchialkarzinom

Drug-eluting balloon: is it useful?

Drug-eluting balloon: is it useful?

Clinical and Preclinical Experience with Gefitinib and Sunitinib

Clinical and Preclinical Experience with Gefitinib and Sunitinib

Dosis-Wirkungsbeziehungen von Gefitinib in einem humanen Lungentumormodell

Dosis-Wirkungsbeziehungen von Gefitinib in einem humanen Lungentumormodell

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib

Radiation myelitis after hypofractionated radiotherapy with concomitant gefitinib

Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung

Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells

Synergistic effect of gefitinib and rofecoxib in mesothelioma cells

Drug-eluting stents vs drug-eluting balloons in patients with small vessel coronary artery disease: a meta-analytic approach

Drug-eluting stents vs drug-eluting balloons in patients with small vessel coronary artery disease: a meta-analytic approach

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib

Verbundene Objekte